'Optimized' LV only pacing using a dual chamber pacemaker as a cost effective alternative to CRT
Maneesh K Rai1, Mukund A Prabhu2, Abhishek Sharma1
1Department of Cardiology, Kasturba Medical College, Mangalore, Karnataka, India.
Indian Pacing and Electrophysiology Journal
|October 27, 2017
Summary
Optimized Left Ventricle Only Pacing (LVOP) offers a cost-effective alternative to Cardiac Resynchronization Therapy (CRT) for heart failure patients with Left Bundle Branch Block. This approach improves NYHA class, reduces QRS duration, and increases ejection fraction.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- Cardiac Resynchronization Therapy (CRT) is underutilized in developing nations due to high costs.
- Left Ventricle Only Pacing (LVOP) is explored as a cost-effective alternative.
Purpose of the Study:
- To evaluate optimized LVOP using 2D strain imaging and ECG as a viable alternative to CRT.
- To assess the feasibility of achieving cardiac synchrony in heart failure patients with LBBB and intact AV conduction.
Main Methods:
- Four patients with symptomatic heart failure underwent LVOP.
- Optimization involved programming AV delay using 12-lead ECG and 2D strain imaging to minimize the difference between Time to Peak longitudinal strain and Aortic valve Closure (Diff TPL-AC).
Main Results:
- The mean optimal AV delay was 150 ms.
- After 6 months, patients improved by at least one NYHA class.
- Mean QRS duration reduced by 54.5 ms, and mean ejection fraction improved by 7%.
Conclusions:
- Optimized LVOP is a cost-effective alternative to CRT for selected heart failure patients.
- This method achieves electrical and mechanical synchrony, leading to significant clinical improvement.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
622
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
622
Cardiomyopathy V: Interprofessional Care
493
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
493
Cardiomyopathy III: Hypertrophic Cardiomyopathy
540
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
540


